KOCHI:Roche India today announced that the Central Drugs Standards Control Organisation (CDSCO) has provided an Emergency Use Authorisation (EUA) for…
MUMBAI: Roche announced that Emicizumab (Hemlibra®) has been approved in India for Hemophilia A with factor VIII Inhibitors. It is…
THIRUVANANTHAPURAM: Roche, a pioneer in innovative diabetes technologies, has signed a Memorandum of Understanding (MOU) with Jothydev’s Diabetes Research Centre…
This website uses cookies.